- Home
- CALC vs CTRM Comparison
CALC vs CTRM Comparison
Compare CALC & CTRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALC
- CTRM
- Stock Information
- Founded
- CALC 2011
- CTRM 2016
- Country
- CALC United States
- CTRM Cyprus
- Employees
- CALC 15
- CTRM N/A
- Industry
- CALC Biotechnology: Pharmaceutical Preparations
- CTRM Marine Transportation
- Sector
- CALC Health Care
- CTRM Consumer Discretionary
- Exchange
- CALC Nasdaq
- CTRM Nasdaq
- Market Cap
- CALC 22.9M
- CTRM 22.9M
- IPO Year
- CALC N/A
- CTRM N/A
- Fundamental
- Price
- CALC $1.43
- CTRM $2.15
- Analyst Decision
- CALC Strong Buy
- CTRM
- Analyst Count
- CALC 3
- CTRM 0
- Target Price
- CALC $16.33
- CTRM N/A
- AVG Volume (30 Days)
- CALC 22.6K
- CTRM 77.7K
- Earning Date
- CALC 08-11-2025
- CTRM 08-07-2025
- Dividend Yield
- CALC N/A
- CTRM N/A
- EPS Growth
- CALC N/A
- CTRM N/A
- EPS
- CALC N/A
- CTRM 0.38
- Revenue
- CALC N/A
- CTRM $66,243,379.00
- Revenue This Year
- CALC N/A
- CTRM N/A
- Revenue Next Year
- CALC N/A
- CTRM N/A
- P/E Ratio
- CALC N/A
- CTRM $5.56
- Revenue Growth
- CALC N/A
- CTRM N/A
- 52 Week Low
- CALC $1.43
- CTRM $1.98
- 52 Week High
- CALC $5.97
- CTRM $5.49
- Technical
- Relative Strength Index (RSI)
- CALC 32.78
- CTRM 42.49
- Support Level
- CALC $1.48
- CTRM $2.09
- Resistance Level
- CALC $1.79
- CTRM $2.33
- Average True Range (ATR)
- CALC 0.12
- CTRM 0.14
- MACD
- CALC -0.02
- CTRM -0.03
- Stochastic Oscillator
- CALC 0.00
- CTRM 12.77
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
About CTRM Castor Maritime Inc.
Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under three reportable segments namely (i) the dry bulk segment (ii) the containership segment and (iii) the asset management segment. It generates maximum revenue from the Dry bulk segment.